Accuracy of Myocardial Blood Flow Estimation From Dynamic Contrast-Enhanced Cardiac CT Compared With PET.
Aged
Blood Flow Velocity
/ physiology
Contrast Media
Coronary Circulation
/ physiology
Female
Humans
Male
Myocardial Ischemia
/ diagnostic imaging
Positron-Emission Tomography
/ methods
Prospective Studies
Radiographic Image Enhancement
/ methods
Reproducibility of Results
Rubidium Radioisotopes
Tomography, X-Ray Computed
/ methods
computed tomography angiography
hemodynamics
myocardial ischemia
perfusion imaging
tomography
Journal
Circulation. Cardiovascular imaging
ISSN: 1942-0080
Titre abrégé: Circ Cardiovasc Imaging
Pays: United States
ID NLM: 101479935
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
entrez:
15
6
2019
pubmed:
15
6
2019
medline:
14
4
2020
Statut:
ppublish
Résumé
Background The accuracy of absolute myocardial blood flow (MBF) from dynamic contrast-enhanced cardiac computed tomography acquisitions has not been fully characterized. We evaluate computed tomography (CT) compared with rubidium-82 positron emission tomography (PET) MBF estimates in a high-risk population. Methods In a prospective trial, patients receiving clinically indicated rubidium-82 PET exams were recruited to receive a dynamic contrast-enhanced cardiac computed tomography exam. The CT protocol included a rest and stress dynamic portion each acquiring 12 to 18 cardiac-gated frames. The global MBF was estimated from the PET and CT exam. Results Thirty-four patients referred for cardiac rest-stress PET were recruited. Of the 68 dynamic contrast-enhanced cardiac computed tomography scans, 5 were excluded because of injection errors or mismatched hemodynamics. The CT-derived global MBF was highly correlated with the PET MBF (r=0.92; P<0.001) with a mean difference of 0.7±26.4%. The CT MBF estimates were within 20% of PET estimates ( P<0.02) with a mean of (1) MBF for resting flow of PET versus CT of 0.9±0.3 versus 1.0±0.2 mL/min per gram and (2) MBF for stress flow of 2.1±0.7 versus 2.0±0.8 mL/min per gram. Myocardial flow reserve was -14±28% underestimated with CT (PET versus CT myocardial flow reserve, 2.5±0.6 versus 2.2±0.6). The proposed rest+stress+computed tomography angiography protocol had a dose length product of 598±76 mGy×cm resulting in an approximate effective dose of 8.4±1.1 mSv. Conclusions In a high-risk clinical population, a clinically practical dynamic contrast-enhanced cardiac computed tomography provided unbiased MBF estimates within 20% of rubidium-82 PET. Although unbiased, the CT estimates contain substantial variance with an standard error of the estimate of 0.44 mL/min per gram. Myocardial flow reserve estimation was not as accurate as individual MBF estimates.
Identifiants
pubmed: 31195817
doi: 10.1161/CIRCIMAGING.118.008323
pmc: PMC6579038
mid: NIHMS1529462
doi:
Substances chimiques
Contrast Media
0
Rubidium Radioisotopes
0
Rubidium-82
9K730EL8KU
Types de publication
Comparative Study
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e008323Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL109327
Pays : United States
Organisme : NHLBI NIH HHS
ID : R56 HL109327
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
Cardiovasc Res. 2001 Apr;50(1):151-61
pubmed: 11282088
Circulation. 2002 Jan 29;105(4):539-42
pubmed: 11815441
Eur J Nucl Med Mol Imaging. 2007 Aug;34(8):1178-88
pubmed: 17334762
N Engl J Med. 2007 Apr 12;356(15):1503-16
pubmed: 17387127
J Nucl Med. 2007 May;48(5):794-801
pubmed: 17475969
J Nucl Cardiol. 2007 May-Jun;14(3):380-97
pubmed: 17556173
J Biopharm Stat. 2007;17(4):571-82
pubmed: 17613642
Eur J Nucl Med Mol Imaging. 2007 Nov;34(11):1765-74
pubmed: 17619189
Invest Radiol. 2007 Dec;42(12):815-22
pubmed: 18007153
J Am Coll Cardiol. 2008 Aug 19;52(8):636-43
pubmed: 18702967
Psychol Bull. 1979 Mar;86(2):420-8
pubmed: 18839484
J Nucl Med. 2009 Jan;50(1):68-71
pubmed: 19091892
Cardiol Clin. 2009 May;27(2):277-89, Table of Contents
pubmed: 19306770
J Am Coll Cardiol. 2009 Jul 7;54(2):150-6
pubmed: 19573732
Invest Radiol. 2010 Jun;45(6):298-305
pubmed: 20421799
JACC Cardiovasc Imaging. 2012 Apr;5(4):430-40
pubmed: 22498334
Circulation. 2012 Oct 9;126(15):1858-68
pubmed: 22919001
J Nucl Med. 2013 Apr;54(4):571-7
pubmed: 23447656
JACC Cardiovasc Imaging. 2014 Mar;7(3):267-77
pubmed: 24529887
F1000Res. 2013 Dec 30;2:288
pubmed: 24555116
Int J Cardiovasc Imaging. 2014 Apr;30(4):803-12
pubmed: 24570085
Phys Med Biol. 2014 Apr 7;59(7):1533-56
pubmed: 24614352
Eur Radiol. 2014 Jul;24(7):1547-56
pubmed: 24744200
Circ Cardiovasc Imaging. 2014 Nov;7(6):930-7
pubmed: 25182366
J Am Coll Cardiol. 2014 Oct 7;64(14):1464-75
pubmed: 25277618
JACC Cardiovasc Imaging. 2014 Nov;7(11):1119-1127
pubmed: 25306543
Eur Heart J Cardiovasc Imaging. 2015 Aug;16(8):900-9
pubmed: 25719181
Eur Radiol. 2016 Feb;26(2):451-8
pubmed: 25991489
J Cardiovasc Comput Tomogr. 2017 Jan - Feb;11(1):16-24
pubmed: 28111212
Front Psychol. 2017 Apr 07;8:456
pubmed: 28439244
Eur Radiol. 2018 Mar;28(3):1253-1256
pubmed: 28956115
Lancet. 2018 Jan 6;391(10115):31-40
pubmed: 29103656
J Nucl Med. 2018 Feb;59(2):273-293
pubmed: 29242396
Eur Radiol. 2018 Jun;28(6):2665-2674
pubmed: 29352381
Int J Cardiol. 2018 May 1;258:325-331
pubmed: 29433968
Phys Med Biol. 2018 May 21;63(10):105020
pubmed: 29701608
Circulation. 1993 Jul;88(1):62-9
pubmed: 8319357
J Nucl Med. 1996 Oct;37(10):1626-31
pubmed: 8862296